基于生物信息学和实验验证的系统分析确定了Alox5作为氏素治疗败血症的新治疗标

Chu-Yun Liu1, Yu-Shen Yang1, Meng-Qin Pei1

  • 1Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.

Annals of medicine
|October 10, 2024
PubMed
概括

素治疗败血症的治疗确定了阿拉基多酸-5-氧化酶 (Alox5) 作为一个关键的目标. 奎尔赛丁有效抑制了Alox5和炎症,这表明Alox5在败血症进展中至关重要.